RecruitingNCT06620770

Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Compliance and Quality of Life

Impact of the Therapeutic Education Program "living with Chronic Inflammatory Disease Under Biotherapy" on Compliance and Quality of Life of Patients


Sponsor

Groupe Hospitalier de Bretagne Sud

Enrollment

126 participants

Start Date

Feb 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Patient therapeutic education programs have been shown to be effective in many specialties, allowing "Improving biological and psychological parameters, allowing patients to improve their health knowledge, therapeutic adherence and sense of personal effectiveness." Several studies have shown that patient knowledge, adherence and satisfaction are better after attending a therapeutic education program. This multidisciplinary program is presented and offered to all patients with chronic disease treated by subcutaneous biotherapy, followed by dermatologists, rheumatologists and gastroenterologists of the Lorient hospital. The study aims to demonstrate the benefit of the Patient Therapeutic Education program at GHBS Lorient "living with a chronic inflammatory disease under biotherapy" on treatment adherence, as well as the positive impact on quality of life.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy.
  • Patients not opposed to their participation in the research.
  • Less than 3 months between inclusion and start of Therapeutic Education Program.

Exclusion Criteria5

  • Subcutaneous injection by another person.
  • Patients with cognitive impairment.
  • Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty.
  • Pregnant women.
  • Persons not covered by social security.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERquestionnaires

Morisky and SF12 Questionnaires delivery at inclusion, 6, 12 and 18 months


Locations(1)

Groupe Hospitalier de Bretagne Sud

Lorient, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06620770


Related Trials